Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Herzig

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Blood|August 1, 1989
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survivalA J Barrett, M M Horowitz, R P Gale, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseD E Reece, M J Barnett, J M Connors, et al.
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Blood|April 1, 1991
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adultsG L Phillips, D E Reece, J D Shepherd, et al.
Cancer|May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantationH M Lazarus, M R Gottfried, R H Herzig, et al.
Blood|January 11, 2000
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registryS Giralt, R Szydlo, J M Goldman, et al.
Mucosal Immunology|November 12, 2015
MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell functionR Brauer, J Tureckova, I Kanchev, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Blood|August 1, 1989
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survivalA J Barrett, M M Horowitz, R P Gale, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseD E Reece, M J Barnett, J M Connors, et al.
Blood|June 1, 1989
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationG L Phillips, S N Wolff, R H Herzig, et al.
Blood|February 15, 1990
The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantationG L Phillips, J W Fay, R H Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Blood|April 1, 1991
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adultsG L Phillips, D E Reece, J D Shepherd, et al.
Cancer|May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantationH M Lazarus, M R Gottfried, R H Herzig, et al.
Blood|January 11, 2000
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registryS Giralt, R Szydlo, J M Goldman, et al.
Mucosal Immunology|November 12, 2015
MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell functionR Brauer, J Tureckova, I Kanchev, et al.
Pageof 17